Research Fellow, MD, PhD
- Translational Radiation Oncology
Following my training in Clinical Oncology at the University of Pisa, from June 2008 to December 2020, I held the position of consultant at Pisa University Hospital, where, from 02/01/2015 to 26/12/2020, I looked after the neuro-oncology multidisciplinary team. I hold a PhD in Clinical Pharmacology, and, in the latter years, my research has been focused on translational studies carried out in brain cancer patients, a new growing field of study in oncology.
Thanks to a fellowship cofounded by the Marie Curie Actions and the Italian Association on Cancer Research (iCARE-2), since January 2021, I have been working for the Department of Oncology of the University of Oxford (Computational Biology and Integrative Genomics lab, headed by Professor Francesca Buffa). By combining artificial intelligence with liquid biopsy, my research aims to explore new approaches for brain tumor patients.
Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy.
Pasqualetti F. et al, (2022), La Radiologia medica
Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.
Pasqualetti F. et al, (2022), Genes (Basel), 13
Early Versus Late Postoperative Radiotherapy in Patients With Prostate Cancer: Results of a Single-centre Retrospective Study.
Pasqualetti F. et al, (2022), Anticancer Res, 42, 2997 - 3001
Sedoheptulose Kinase SHPK Expression in Glioblastoma: Emerging Role of the Nonoxidative Pentose Phosphate Pathway in Tumor Proliferation.
Franceschi S. et al, (2022), Int J Mol Sci, 23
Role of magnetic resonance imaging following postoperative radiotherapy in clinical decision-making of patients with high-grade glioma.
Pasqualetti F. et al, (2022), Radiol Med